← Eichor
Condition: Narcolepsy Type 2 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Narcolepsy Type 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central
Phase 2/Phase 3 · 7 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07598708A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 2 · 24 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07096674Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05773872A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Phase 2 · 57 location(s) · Eisai Inc. · NCT07493265A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Phase 2 · 52 location(s) · Takeda · NCT06952699A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Phase 2/Phase 3 · 46 location(s) · Alkermes, Inc. · NCT06767683A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia
NA · 1 location(s) · University of Sydney · NCT07006233Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Phase 3 · 19 location(s) · Alkermes, Inc. · NCT07502443A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 2 · 37 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT06752668Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
Phase N/A · 10 location(s) · Takeda · NCT07299097A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
Phase 2/Phase 3 · 1 location(s) · Takeda · NCT07646678
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.